164 related articles for article (PubMed ID: 17502565)
1. Effects of rivastigmine on cognitive function in patients with traumatic brain injury.
Noble JM; Hauser WA
Neurology; 2007 May; 68(20):1749; author reply 1750. PubMed ID: 17502565
[No Abstract] [Full Text] [Related]
2. Effects of rivastigmine on cognitive function in patients with traumatic brain injury.
Silver JM; Koumaras B; Chen M; Mirski D; Potkin SG; Reyes P; Warden D; Harvey PD; Arciniegas D; Katz DI; Gunay I
Neurology; 2006 Sep; 67(5):748-55. PubMed ID: 16966534
[TBL] [Abstract][Full Text] [Related]
3. Central acetylcholinesterase inhibitors in the treatment of chronic traumatic brain injury-clinical experience in 111 patients.
Tenovuo O
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):61-7. PubMed ID: 15610946
[TBL] [Abstract][Full Text] [Related]
4. Rivastigmine for the treatment of dementia in patients with progressive supranuclear palsy: Clinical observations as a basis for power calculations and safety analysis.
Liepelt I; Gaenslen A; Godau J; Di Santo A; Schweitzer KJ; Gasser T; Berg D
Alzheimers Dement; 2010 Jan; 6(1):70-4. PubMed ID: 20129321
[TBL] [Abstract][Full Text] [Related]
5. [The role of rivastigmine (exelon) in the treatment of consequences of cranial-brain trauma].
Kondrat'eva EA; Borovikova VN; Kondrat'ev SA; Driagina NV; Voronenko VA
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(1):55-8. PubMed ID: 19156088
[TBL] [Abstract][Full Text] [Related]
6. [Rivastigmine solution prescribing habits in patients with Alzheimer-type dementia in Spain (RIVASOL study)].
González-Gutiérrez JL; Gobartt AL;
Rev Neurol; 2007 Jun 16-30; 44(12):705-10. PubMed ID: 17583861
[TBL] [Abstract][Full Text] [Related]
7. Two years' follow-up of rivastigmine treatment in Huntington disease.
de Tommaso M; Difruscolo O; Sciruicchio V; Specchio N; Livrea P
Clin Neuropharmacol; 2007; 30(1):43-6. PubMed ID: 17272969
[TBL] [Abstract][Full Text] [Related]
8. Identification of responders and reactive domains to rivastigmine in Alzheimer's disease.
Frankfort SV; Appels BA; de Boer A; Tulner LR; van Campen JP; Koks CH; Beijnen JH; Schmand BA
Pharmacoepidemiol Drug Saf; 2007 May; 16(5):545-51. PubMed ID: 17109476
[TBL] [Abstract][Full Text] [Related]
9. Effects of rivastigmine on motor and cognitive impairment in Huntington's disease.
de Tommaso M; Specchio N; Sciruicchio V; Difruscolo O; Specchio LM
Mov Disord; 2004 Dec; 19(12):1516-8. PubMed ID: 15390067
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations.
Kumar P; Kumar A
Eur J Pharmacol; 2009 Aug; 615(1-3):91-101. PubMed ID: 19445928
[TBL] [Abstract][Full Text] [Related]
11. [Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
Moerkens RM; Dhondt AD
Ned Tijdschr Geneeskd; 2003 Apr; 147(14):679; author reply 679. PubMed ID: 12712654
[No Abstract] [Full Text] [Related]
12. [Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
Mol JA
Ned Tijdschr Geneeskd; 2003 Apr; 147(14):679; author reply 679. PubMed ID: 12712655
[No Abstract] [Full Text] [Related]
13. Dementia treatment update.
Buffum MD; Buffum JC
Geriatr Nurs; 2005; 26(2):74-8. PubMed ID: 15824717
[No Abstract] [Full Text] [Related]
14. [Pharmacotherapy of the cognitive sequelae secondary to traumatic brain injury].
Riós-Romenets S; Castaño-Monsalve B; Bernabeu-Guitart M
Rev Neurol; 2007 Nov 1-15; 45(9):563-70. PubMed ID: 17979087
[TBL] [Abstract][Full Text] [Related]
15. Rivastigmine, a brain-selective acetylcholinesterase inhibitor, ameliorates cognitive and motor deficits induced by closed-head injury in the mouse.
Chen Y; Shohami E; Constantini S; Weinstock M
J Neurotrauma; 1998 Apr; 15(4):231-7. PubMed ID: 9555969
[TBL] [Abstract][Full Text] [Related]
16. Effects of rivastigmine on memory and cognition in multiple sclerosis.
Shaygannejad V; Janghorbani M; Ashtari F; Zanjani HA; Zakizade N
Can J Neurol Sci; 2008 Sep; 35(4):476-81. PubMed ID: 18973065
[TBL] [Abstract][Full Text] [Related]
17. [Rivastigmine in the treatment of dementia: from the symptomatic effect to neuroprotection].
Damulin IV
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(9):76-82. PubMed ID: 21246897
[No Abstract] [Full Text] [Related]
18. [Hallucinations associated to treatment with rivastigmine in two patients with diffuse Lewy body disease].
Alonso-Navarro H; Jiménez-Jiménez FJ
Rev Neurol; 2007 May 1-15; 44(9):575-6. PubMed ID: 17492618
[No Abstract] [Full Text] [Related]
19. Cognitive impairments following traumatic brain injury. Etiologies and interventions.
Davis AE
Crit Care Nurs Clin North Am; 2000 Dec; 12(4):447-56. PubMed ID: 11855248
[TBL] [Abstract][Full Text] [Related]
20. Rivastigmine in Wernicke-Korsakoff's syndrome: five patients with rivastigmine showed no more improvement than five patients without rivastigmine.
Luykx HJ; Dorresteijn LD; Haffmans PM; Bonebakker A; Kerkmeer M; Hendriks VM
Alcohol Alcohol; 2008; 43(1):70-2. PubMed ID: 17984137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
